Abstract
In 2000 the Iwokrama International Centre for Rainforest Conservation and Development (IIC), Guyana embarked on a bioprospecting and bioinventory project of endophytic fungi and their plant hosts in partnership with other institutions. The project was called the Conservation and Sustainable Utilization of Biodiversity in the Iwokrama Forest (CSUBIF) programme and was funded by the European Commission (EC). The main objectives were (a) establishment of a bioprospecting-bioinventory laboratory in Guyana, (b) an inventory of Iwokrama’s unknown endophytic fungi, (c) isolation of bioactive natural compounds from fungal endophytes and host plants, and (d) development/commercialisation of natural products. A local laboratory was established at the University of Guyana to collect, identify and analyse samples. The project was an overall success having identified (a) hitherto unknown endophytic fungi and (b) 110 fungal and 29 plant extract leads for further research and development. The major constraints of the project was its short duration, lack of Intellectual Property Rights (IPR) agreements and access to genetic resources and benefit sharing (ABS) protocols. There has never been a more important time to reassess efforts such as the Iwokrama Bioprospecting Project, given the current crisis caused by resistant bacterial and fungal diseases and the lack of effective antibiotics with which to treat them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arnold AE, Maynard Z, Gilbert GS (2001) Fungal endophytes in dicotyledonous neotropical trees: patterns of abundance and diversity. Mycol Res 105(12):1502–1507
Baines G, Warner R (2000) Guyana 1999 – Iwokrama Rain Forest Programme – Project evaluation report GEF ASSISTANCE TO THE IWOKRAMA RAIN FOREST PROGRAMME Project Number GUY/92/G31/A/1G/99 Draft Report of the Final Project Evaluation Mission Final Project Evaluation, GUY/92/G31/A/1G/99. https://www.academia.edu/2085038/Guyana_1999_-_Iwokrama_Rain_Forest_Programme_-Project_evaluation_report. Accessed 26 June 2015
Bergstrom JD, Dufresne C, Bills GF, Nallin-Omstead M, Byrne K (1995) Discovery, biosynthesis and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. Annu Rev Microbiol 49:607–639
Bhatnagar I, Kim SK (2010) Immense essence of excellence: marine microbial bioactive compounds. Mar Drugs 8(10):2673–2701
Blackwell M (2011) The fungi: 1, 2, 3... 5.1 million species? Am J Bot 98(3):426–438
Braine T, (2011) Race against time to develop new antibiotics. In: Bulletin of the World Health Organization 89:88-89 doi:10.2471/BLT11.030211.http://www.who.int/bulletin/volumes/89/2/11-030211/en/. Accessed 11 July 2015
Butler MS (2004) The role of natural product chemistry in drug discovery. J Nat Prod 67(12):2141–2153
Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25(3):475–516. doi:10.1039/b514294f
Butler MS, Robertson AAB, Cooper MA (2014) Natural product and natural product derived drugs in clinical trials. Nat Prod Rep 31(11):1612–1661
Cannon PF (1996) Filamentous fungi. In: Hall GS (ed) Methods for the examination of organismal diversity in soils and sediments. CABI, Wallingford, pp. 125–143
Cannon PF, Hawksworth DL (1995) The diversity of fungi associated with vascular plants: the known, the unknown and the need to bridge the knowledge gap. In: Andrews JH, Tommerup IC (eds) Advances in plant pathology, vol 11. Academic Press, London, pp. 277–302
Cannon PF, Reid A, Simmons CM (2002) Diversity and host preference of leaf endophytic fungi in the Iwokrama forest reserve, Guyana. Mycologia 94(2):210–220
Castree N (2003) Bioprospecting: from theory to practice (and back again). Trans Inst Br Geogr 28(1):35–55. doi:10.1111/1475-5661.00076
Chin Y-W, Balunas MJ, Chai HB, Kinghorn AD (2006) Drug discovery from natural sources. AAPS J 8(2):E239–E253
Clarke HD, Funk VA, Hollowell T (2001) Using checklists and collections data to investigate plant diversity I: a comparative checklist of the plant diversity of the Iwokrama forest, Guyana. In: BL Lipscomb (ed) SIDA, Botanical Miscellany, no 21 Botanical Research Institute of Texas, Forth Worth, pp 1–86
Clay K (1988) Clavicipitaceous fungal endophytes of grasses: coevolution and the change from parasitism to mutualism. In: Pirozynski KA, Hawksworth DL (eds) Coevolution of fungi with plants and animals. Academic Press, London, pp. 79–105
Clay K (1990) Fungal endophytes of grasses. Annu Rev Ecol Syst 21:275–297
Conniff R (2012) A bitter pill. Conservation 13(1):18–23
Cordell GA, Colvard MD (2005) Some thoughts on the future of ethnopharmacology. J Ethnopharmacol 100(1-2):5–14
Domsch KH, Gams W, Anderson T-H (1993) Compendium of soil fungi, 2nd edn, 2 vols. Academic Press, London
Dreyfuss MM, Chapela IH (1994) Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals. In: Gullo VP (ed) Discovery of natural products with therapeutic potential. Butterworth-Heinemann, Boston, pp. 49–80
Durgante FM, Higuchi N, Almeida A, Vicentini A (2013) Species spectral signature: discriminating closely related plant species in the Amazon with near-infrared leaf-spectroscopy. For Ecol Manag 291:240–248
Engstrom MD, Lim BK, Reid FA (1999) Guide to the mammals of Iwokrama. http://www.iwokrama.org/mammals/. Accessed 26 June 2015.
European Centre for Disease Prevention and Control (2009) ECDC/EMEA joint technical report the bacterial challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf . Accessed 14 Dec 2015
Firn RD (2003) Bioprospecting – why is it so unrewarding? Biodivers Conserv 12(2):207–216
Gámez R (2007) The link between biodiversity and sustainable development: lessons from INBio’s bioprospecting program in Costa Rica. In: McManis CR (ed) Biodiversity and the law: intellectual property, biotechnology and traditional knowledge. Earthscan, London, pp. 77–90
Garner C, Brown D (2015) Spotlight on antibiotic research UK. Biochemist 37(3):36–37
Giddings L-A, Newman DJ (2013) Microbial natural products: molecular blueprints for antitumor drugs. J Ind Microbiol Biotechnol 40(11):1181–1210
Gilmour D (1999) Rainforest pioneer. Millennium trailblazers 3: David Cassell. People & the Planet/IPPF, UNFPA, IUCN 8(4):20
Guérin-McManus M, Famolare L, Bowles IA, Malone SAJ, Mittermeier R, and Rosenfeld AB (2011) Bioprospecting in practice: a case study of the suriname ICBG project and benefits sharing under the convention on biological diversity. Montreal: Report for Convention on Biological Diversity, 11 2001
Gutierrez RMP, Gonzalez AMN, Ramirez AM (2012) Compounds derived from endophytes: a review of phytochemistry and pharmacology. Curr Med Chem 19(18):2992–3030
Guzman-Trampe S, Rodriguez-Peña K, Espinosa-Gómez A, Sánchez-Fernández RE, Macias-Rubalcava ML, Flores-Cotera LB, Sánchez S (2015) Endophytes as a potential source of new antibiotics. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, pp. 175–204
Hammond P (1992) Species inventory. In: Groombridge B (ed) Global biodiversity: status of the earth’s living resources. Chapman and Hall, London, pp. 17–39
Harvey AL, Gericke N (2011) Bioprospecting: creating a value for biodiversity. In: Pavlinov IY (ed) Research in biodiversity – models and applications. Available via INTECH. http://www.intechopen.com/books/research-in-biodiversity-models-and-applications/bioprospecting-creating-a-value-for-biodiversity . Accessed 20 Dec 2015
Hawksworth DL (1991) The fungal component of biodiversity: magnitude, significance and conservation. Mycol Res 95(6):641–655
Hawksworth DL (2012) Global species numbers of fungi: are tropical studies and molecular approaches contributing to a more robust estimate? Biodivers Conserv 21(9):2425–2433
Insanally R (ed) (2003) The cropper foundation report on the conference “Development as if Equity Mattered”. Georgetown Guyana September 24-26, 2001, Port of Spain, Trinidad and Tobago
Iwokrama International Centre for Rain Forest Conservation and Development (2015) News Archives. http://iwokrama.org/2014/07/iwokrama-issues-request-for-proposals-for-its-science-and-research-programme/ . Accessed 16 June 2015
Kelley J, Cannon P, Simmonds M, Pingal R and Simmons C (2003) The Iwokrama programme: an approach to the sustainable exploitation of genetic resources. In: Biological resource centres and the use of microbes. Lima N, Smith D (eds) XXII ECCO Meeting Proceedings Book 185–195
Kingston DGI (2011) Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod 74(3):496–511
Koehn FE (2008a) High impact technologies for natural products screening. In: Petersen F, Amstutz R (eds) Natural compounds as drugs volume I, Progress in drug research, vol 65. Birkhäuser, Basel, pp. 175–210
Koehn FE (2008b) New strategies and methods in the discovery of natural product anti-infective agents: the mannopeptimycins. J Med Chem 51(9):2613–2617
Lesser WH, A Krattiger (2007) Valuation of bioprospecting samples: approaches, calculations, and implications for policy-makers. In: (Krattiger A, Mahoney RT, Nelsen L, et al.) Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices, vols 1 and 2 Chap 9.4, pp. 861-876 MIHR: Oxford, U.K., and PIPRA: Davis, U.S.A. (accessed December 5 2015) Available online at www.ipHandbook.org
Lewis R (1995) The rise of antibiotic-resistant infections. FDA Consum 29(7):11–15
Li JW-H, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325(5937):161–165
Lim BK, Engstrom MD (2001a) Species diversity of bats (Mammalia: Chiroptera) in Iwokrama forest, Guyana, and the Guianan subregion: implications for conservation. Biodivers Conserv 10(4):613–657
Lim BK, Engstrom MD (2001b) Bat community structure at Iwokrama forest, Guyana. J Trop Ecol 17(5):647–665. doi:10.1017/S0266467401001481
Lim BK, Engstrom MD (2005) Mammals of Iwokrama forest. Proceedings of the Academy of Natural Sciences of Philadelphia 154(1):71-108doi: http://dx.doi.org/10.1635/0097-3157(2004)154[0071:MOIF]2.0.CO;2
Lu G, Cannon PF, Reid A, Simmons CM (2004) Diversity and molecular relationships of endophytic Colletotrichum isolates from the Iwokrama forest reserve, Guyana. Mycol Res 108(1):53–63
Lv Y-L, Zhang F-S, Chen J, Cui J-L, Xing Y-M, Li X-D, Guo S-X (2010) Diversity and antimicrobial activity of endophytic fungi associated with the alpine plant Saussurea involucrata. Biol Pharm Bull 33(8):1300–1306
Márqueza SS, Bills GF, Herrero N, Zabalgogeazcoaa Í (2012) Non-systemic fungal endophytes of grasses. Fungal Ecol 5(3):289–297
McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R, Hinkle M, Whitman T, Lesho E, Schaecher KE (2016) Escherichia coli Harboring mcr-1 and blaCTX-M on a novel IncF plasmid: fFirst report of mcr-1 in the USA. Antimicrob Agents Chemother. doi:10.1128/AAC.01103-16
Monette M, Simpson A, Masoom H, Liaghati Y, Mobarhan Courtier-Murias D, Fortier-McGill B, Soong R, KL Colson (2015) Characterization of environmental samples in their natural state using comprehensive multiphase NMR. In: 2015 Annual Meeting of the ASP, July 25th–29th, 2015, Copper Mountain, CO, USA
Mousa WK, Raizada MN (2013) The diversity of anti-microbial secondary metabolites produced by fungal endophytes: an interdisciplinary perspective. Front Microbiol 4:65
Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70(3):461–477
Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S (2009) Natural compounds for cancer treatment and prevention. Pharmacol Res 59(6):365–378
Nisa H, Kamili AN, Nawchoo IA, Shafi S, Shameem N, Bandh SA (2015) Fungal endophytes as prolific source of phytochemicals and other bioactive natural products: a review. Microb Pathog 82:50–59
O’Brien HE, Parrent JL, Jackson JA, Moncalvo J-M, Vilgalys R (2005) Fungal community analysis by large-scale sequencing of environmental samples. Appl Environ Microbiol 71(9):5544–5550
Omacini M, Chaneton EJ, Ghersa CM, Muller CB (2001) Symbiotic fungal endophytes control insect host-parasite interaction webs. Nature 409(6816):78–81
Overbye KM, Barrett JF (2005) Antibiotics: where did we go wrong? Drug Discov Today 10(1):45–52
Pingal R (2001) From tropical rain forest to pharmaceuticals and other bioactive compounds: the process of discovery. Paper presented at Iwokrama Brown Bag Lunch Seminar, Iwokrama Centre, Bel Air, Georgetown, Guyana 14 February 2001
Pingal R (2002a) Challenges in using biodiversity. Paper presented at the international workshop on national biodiversity systems: building inter-generational capabilities for conservation and sustainable use, Georgetown, Guyana, July 2002
Pingal R (2002b) Iwokrama’s bodiversity prospecting programme. Paper presented at the 5th International inter-Guianas conference on the development of the Guianas: building capacity to meet the emerging challenges in the Guianas, University of Guyana, Turkeyen, Guyana, 22-25 October 2002
Pingal R (2002c) Physical and chemical properties of crabwood oil: requirements for export. Paper presented at the international workshop on critical issues in the market and sustainable and equitable use of crabwood oil in Guyana, Lake Mainstay Resort, Essequibo, Guyana, 23-24 November 2002
Pingal R, McTurk M (2002) Biodiversity prospecting in the Iwokrama forest. Paper presented at the Friends of Iwokrama Public Seminar, Iwokrama Centre, Bel Air, Georgetown, Guyana, 7 June 2002
Pingal R, Simmons C, Cannon P, Paterson R, Simmonds M, Kokubun T, Mootoo B, Maxwell A and Jacobs H (2001) Iwokrama’s bioprospecting programme: Paper presented at the Caribbean Academy of Sciences 12th General Meeting and Conference, Georgetown, Guyana 4-9 June 2001
Pingal R, Simmons C, Cannon P, Paterson R, Simmonds M, Kokubun T, Mootoo B, Maxwell A and Jacobs H (2002) Bioprospecting for bioactive metabolites from endophytic fungi and plants of the Iwokrama forest. Paper presented at the 19th Mona Symposium on Natural Products and Medicinal Chemistry, the University of the West Indies, Mona, Jamaica, 7-10 January 2002
Rossman AY (1994) A strategy for an all-taxa inventory of fungal biodiversity. In: Peng C-I, Chou CH (eds) Biodiversity and terrestrial ecosystems, academia sinica monograph series no 14, Institute of Botany, Tapiei, p 1691-1694
Rossman AY, Tulloss RE, O’Dell TE, Thorn RG (1998) Protocols for an all taxa biodiversity inventory of fungi in a Costa Rican conservation area. Parkway, Boone
Saikkonen K, Gundel PE, Helander M (2013) Chemical ecology mediated by fungal endophytes in grasses. J Chem Ecol 39(7):962–968
Saurí J, Chan STS, Buevich V, Gustafson KR, Williamson T, Martin GE (2015) Structure elucidation of a proton-deficient natural product using LR-HSQMBC supported by DFT calculations. Paper presented at the ASP 2015 annual meeting, Copper Mountain, Colorado 25-29 July 2015
Shrivastava G, Ownley BH, Auge RM, Toler H, Dee M, Vu AK, Tobias G, Chen F (2015) Colonization by arbuscular mycorrhizal and endophytic fungi enhanced terpene production in tomato plants and their defense against a herbivorous insect. Symbiosis 65(2):65–74
Simmons C (2002a) Iwokrama’s bioinventory/bioprospecting programme. Paper presented at the 5th international inter-Guianas conference on the development of the Guianas: building capacity to meet the emerging challenges in the Guianas, University of Guyana, Turkeyen, Guyana, 22-25 October 2002
Simmons C (2002b) Iwokrama – efforts towards the conservation and sustainable utilization of the Iwokrama forest. Paper presented at the Caribbean Herbs Business Forum, Montego Bay, Jamaica, 2 – 5 December 2002
Simmons C (2002c) Medicinal plants of the Iwokrama reserve. Paper presented at the Natural Products Institute University of the West Indies, Mona Campus 6 – 7 December 2002
Simmons C, Cannon PF (2002) Diversity and host preference of leaf endophytic fungi in the Iwokrama forest reserve, Guyana. Paper presented at 7th International Mycological Congress, University of Oslo, Norway, 11 – 17 August 2002
Simons L, Bultman TL, Sullivan TJ (2008) Effects of methyl jasmonate and an endophytic fungus on plant resistance to insect herbivores. J Chem Ecol 34(12):1511–1517
Smith PG, Kerry SM (1996) The Iwokrama rain forest programme for sustainable development: how much of Guyanaʼs bat (Chiroptera) diversity does it encompass? Biodivers Conserv 5(7):921–942
Sneader W (1996) Drug prototypes and their exploitation. Wiley, Chichester 788 pp
von Arx JA (1980) The genera of fungi sporulating in pure culture, 3rd edn. Lubrecht & Cramer, Vaduz
Xiong M, Guo Z, Han B, Chen M (2015) Combating multidrug resistance in bacterial infection by targeting functional proteome with natural products. Nat Prod Res 29(17):1624–1629
Zhao J, Shan T, Mou Y, Zhou L (2011) Plant-derived bioactive compounds produced by endophytic fungi. Mini-Rev Med Chem 11(2):159–168
Acknowledgement
The EC is gratefully acknowledged for its funding of the Conservation and Sustainable Utilisation of Biodiversity in the Iwokrama Forest EC Project B7-6021/98-02/VIII/FOR Guyana of which bioprospecting was a component.
Disclaimer
The views expressed in this article do not necessarily reflect those held by the European Commission nor the International Board of Trustees, management and staff of the Iwokrama Centre for Rain Forest Conservation and Development.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Pingal, R. (2017). Iwokrama Fungal/Plant Bioprospecting Project 2000–2003 – A Model for the Future?. In: Paterson, R., Lima, N. (eds) Bioprospecting. Topics in Biodiversity and Conservation, vol 16. Springer, Cham. https://doi.org/10.1007/978-3-319-47935-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-47935-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47933-0
Online ISBN: 978-3-319-47935-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)